This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Anti-Rabies Serum industry.
What is the anticipated market size of the anti-rabies serum industry over the next few years?
The anti-rabies serum market size has grown strongly in recent years. It will grow from $1.42 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to growth in animal populations, expansion of vaccination programs, improved diagnostic techniques, increased travel and migration, and rising public health initiatives, rising incidence of wildlife encounters.
The anti-rabies serum market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the rising incidence of animal bites, increased funding for rabies research, rising awareness of zoonotic diseases, improvement in serum storage and handling, and enhanced support for rabies control programs. Major trends in the forecast period include the development of new serum formulations, advancements in healthcare infrastructure, technological advancements in serum production, the development of alternative delivery systems, and the development of rapid diagnostic kits.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp
What emerging drivers are expected to shape the future of the anti-rabies serum market?
The rise in the prevalence of dog bites is expected to propel the growth of the anti-rabies serum market going forward. Dog bites refer to injuries caused when a dog bites or scratches a person, which can vary from minor to severe. These bites can lead to infections, serious wounds, and, in some cases, transmission of diseases such as rabies. Effective prevention and prompt medical treatment are crucial for managing and mitigating the risks associated with dog bites. The rise in the prevalence of dog bites is due to several factors, such as increased urbanization leading to more frequent interactions between people and dogs, a higher number of unrestrained or poorly trained dogs, and insufficient awareness or education about dog behavior and bite prevention. The rise in the prevalence of dog bites has led to increased demand for anti-rabies serum, as timely administration of the serum is crucial for preventing the onset of rabies in individuals exposed to potentially infected animals. For instance, in 2023, according to the American Veterinary Medical Association, a US-based non-profit organization, the average cost for dog bite insurance claims in 2023 was $58,545 Insurers paid out $1.12B in liability claims related to dog bites and other dog-related injuries in 2023. Dog bite claims increased by nearly 10% in 2023. Therefore, the rise in the prevalence of dog bites is driving the growth of the anti-rabies serum market.
What emerging segments are shaping the future landscape of the anti-rabies serum industry?
The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals
Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report
#What are the top market trends driving innovation in the anti-rabies serum industry?
Major companies in the anti-rabies serum market are adopting strategic partnerships to enhance product development and expand market reach. Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in July 2023, Kedrion S.p.A, a US-based biopharmaceutical company partnered with Kamada an Israel-based biopharmaceutical company to distribute KEDRAB (Rabies Immune Globulin [Human]) in the US. This collaboration has been instrumental in co-developing and licensing the product in the U.S., while also raising disease awareness. Through their efforts, the partnership has helped protect individuals exposed to rabid animal bites from serious and potentially life-threatening conditions.
#How are key players in the anti-rabies serum market strengthening their market position?
Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd ., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals
Which geographic areas are contributing significantly to the growth of the anti-rabies serum sector?
North America was the largest region in the anti-rabies serum market in 2024. The regions covered in the anti-rabies serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Anti-Rabies Serum Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20468
Need Customized Data On Anti-Rabies Serum Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20468&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
